文献速递主动脉外科

开窗/分支支架腔内修复胸腹主动脉瘤的早中期结果

Endovascular repair of thoraco-abdominal aortic aneurysms by fenestrated and branched endografts†.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

30天死亡率为5%,院内死亡率为8%,脊髓缺血发生率为6%,12、24、36个月生存率分别为89%、75%、70%。结论认为该技术可行有效,早中期技术/临床结果可接受。

要点

  • 高手术风险胸腹主动脉瘤患者行开窗/分支支架腔内修复,30天死亡率为5%。
  • 脊髓缺血发生率为6%,永久性截瘫发生率为3%。
  • 12、24、36个月靶内脏血管通畅率均为92%。

核心结论

  • 开窗/分支支架腔内修复胸腹主动脉瘤可行有效,早中期技术/临床结果可接受。

主要发现

  • 30天死亡率为5%,院内死亡率为8%,术中死亡1例(1%)。
  • 脊髓缺血发生率为6%,永久性截瘫发生率为3%;术后心脏和肺部并发症发生率分别为8%和14%。
  • 肾功能恶化(≥基线30%)发生率为13%,需血液透析者为2%。
  • 12、24、36个月生存率分别为89%、75%、70%,靶内脏血管通畅率均为92%,免于再干预率分别为85%、85%、83%。

关键数值与推荐

  • 30天和院内死亡率分别为5%和8%。
  • 脊髓缺血发生率为6%,永久性截瘫发生率为3%。
  • 12、24、36个月靶内脏血管通畅率均为92%。
  • 12、24、36个月免于再干预率分别为85%、85%、83%。

临床怎么用

  • 对于高手术风险的胸腹主动脉瘤患者,开窗/分支支架腔内修复可作为可行治疗选择,需关注脊髓缺血和肾功能恶化风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Our objective was to report the outcomes of fenestrated/branched endovascular aneurysm repair of thoraco-abdominal aortic aneurysms (TAAAs) with endografts. METHODS: Between January 2010 and April 2018, patients with TAAAs, considered at high surgical risk for open surgery and treated by Cook-Zenith fenestrated/branched endovascular aneurysm repair, were prospectively enrolled and retrospectively analysed. The early end points were 30-day/hospital mortality rate, spinal cord ischaemia and 30-day cardiopulmonary and nephrological morbidity. Follow-up end points were survival, patency of target visceral vessels and freedom from reinterventions. RESULTS: Eighty-eight patients (male: 77%; mean age: 73 ± 7 years; American Society of Anesthesiologists 3/4: 58/42%) were enrolled. Using Crawford's classification, 43 (49%) were types I-III and 45 (51%) were type IV TAAAs. The mean aneurysm diameter was 65 ± 15 mm. Custom-made and off-the-shelf endografts were used in 60 (68%) and 28 (32%) cases, respectively. Five (6%) patients had a contained ruptured TAAA. The procedure was performed in multiple steps in 42 (48%) cases. There was 1 (1%) intraoperative death. Five (6%) patients suffered spinal cord ischaemia with permanent paraplegia in 3 (3%) cases. Postoperative cardiac and pulmonary complications occurred in 7 (8%) and 12 (14%) patients, respectively. Worsening of renal function (≥30% of baseline level) was detected in 11 (13%) cases, and 2 (2%) patients required haemodialysis. The 30-day and hospital mortality rates were 5% and 8%, respectively. The mean follow-up was 36 ± 22 months. Survival at 12, 24 and 36 months was 89%, 75% and 70%, respectively. The patency of target visceral vessels at 12, 24 and 36 months was 92%, 92% and 92%, respectively. Freedom from reinterventions at 12, 24 and 36 months was 85%, 85% and 83%, respectively. CONCLUSIONS: The endovascular repair of TAAAs with fenestrated/branched endovascular aneurysm repair is feasible and effective with acceptable technical/clinical outcomes at early/midterm follow-up.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Gallitto E, Faggioli G, Pini R, et al. Endovascular repair of thoraco-abdominal aortic aneurysms by fenestrated and branched endografts†. Eur J Cardiothorac Surg. 2019. PMID: 31323677. doi:10.1093/ejcts/ezz125

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。